The optimal timing and modality of therapeutic intervention during early phases of HIV infection is still debated; in our prospective observational study we evaluated immunological and virological outcome in HIV+ patients treated during acute or recent HIV infection.
Treatment outcome in HIV+ patients receiving 3- or 4-drug regimens during PHI / G.M. Bottani, M.L. Oreni, G. Orofino, P. Tau, S. Di Nardo Stuppino, E. Colella, S. Carosella, M. Guastavigna, V. Ghisetti, V. Micheli, M. Galli, S. Rusconi. - In: JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. - ISSN 1758-2652. - 17:4, suppl. 3(2014 Nov 02), pp. 19778.175-19778.175. ((Intervento presentato al convegno International congress of drug therapy in HIV infection tenutosi a Glasgow (UK) nel 2014 [10.7448/IAS.17.4.19778].
Treatment outcome in HIV+ patients receiving 3- or 4-drug regimens during PHI
P. Tau;E. Colella;V. Micheli;M. GalliPenultimo
;S. RusconiUltimo
2014
Abstract
The optimal timing and modality of therapeutic intervention during early phases of HIV infection is still debated; in our prospective observational study we evaluated immunological and virological outcome in HIV+ patients treated during acute or recent HIV infection.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
